These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21559457)

  • 1. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma.
    Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S
    PLoS One; 2011 Apr; 6(4):e19103. PubMed ID: 21559457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
    Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
    Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.
    Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C
    Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma.
    Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA
    PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.
    Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
    Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
    Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
    Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
    Sodhi A; Montaner S; Gutkind JS
    FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
    Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S
    Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
    Martin D; Nguyen Q; Molinolo A; Gutkind JS
    Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma.
    Montaner S
    Cell Cycle; 2007 Feb; 6(4):438-43. PubMed ID: 17329974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia.
    Montaner S; Sodhi A; Servitja JM; Ramsdell AK; Barac A; Sawai ET; Gutkind JS
    Blood; 2004 Nov; 104(9):2903-11. PubMed ID: 15231571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.
    Sodhi A; Montaner S; Patel V; Zohar M; Bais C; Mesri EA; Gutkind JS
    Cancer Res; 2000 Sep; 60(17):4873-80. PubMed ID: 10987301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineoplastic effect of 1α,25(OH)
    Suares A; Tapia C; González-Pardo V
    J Steroid Biochem Mol Biol; 2019 Feb; 186():122-129. PubMed ID: 30308321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma.
    Ma T; Jham BC; Hu J; Friedman ER; Basile JR; Molinolo A; Sodhi A; Montaner S
    Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14363-8. PubMed ID: 20660728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-like 4: a novel molecular hallmark in oral Kaposi's sarcoma.
    Hu J; Jham BC; Ma T; Friedman ER; Ferreira L; Wright JM; Accurso B; Allen CM; Basile JR; Montaner S
    Oral Oncol; 2011 May; 47(5):371-5. PubMed ID: 21421336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains.
    Haque M; Kousoulas KG
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.
    Chaisuparat R; Hu J; Jham BC; Knight ZA; Shokat KM; Montaner S
    Cancer Res; 2008 Oct; 68(20):8361-8. PubMed ID: 18922908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal adhesion kinase is required for KSHV vGPCR signaling.
    He M; Bakken T; Kassimova A; Boshoff C; Philpott N; Cannon ML
    Mol Carcinog; 2012 Apr; 51(4):339-51. PubMed ID: 21538577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.
    Bais C; Van Geelen A; Eroles P; Mutlu A; Chiozzini C; Dias S; Silverstein RL; Rafii S; Mesri EA
    Cancer Cell; 2003 Feb; 3(2):131-43. PubMed ID: 12620408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.